Psychemedics GAAP EPS of -$0.14, revenue of $4.7M

Stock Information for Psychemedics Cor

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Psychemedics Cor

Psychemedics Releases 2025 Workforce Insights Report
Psychemedics Named "Most Innovative Drug Testing Company of the Year"
Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
Psychemedics Corporation Announces Reverse and Forward Stock Split
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
Psychemedics Corporation Launches New Ketamine Hair Testing Service

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.